EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Development and Initial Results from the Canadian Cardiac Amyloidosis Pyrophosphate Imaging Registry (CAPER)

Cigdem Akincioglu, Natasha Aleksova, Nowell Fine, Daniel Juneau, Terrence D Ruddy, Gary Small, Matthieu Pelletier-Galarneau, Glenn Wells, Robert J H Miller

Canadian Journal of Cardiology · 2025

DOI: 10.1016/j.cjca.2025.08.357 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Canadian Journal of Cardiology, 2025. Verfasst von Cigdem Akincioglu und 8 weiteren Autor:innen. Beteiligte Einrichtung: University of Western Ontario, Medical Imaging, Division of Nuclear Medicine, London, Ontario, Canada. Hauptthemen laut MEDLINE: Registries, Amyloid Neuropathies, Familial, Technetium Tc 99m Pyrophosphate, Cardiomyopathies. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Pfizer Canada ULC, Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RegistriesAmyloid Neuropathies, FamilialTechnetium Tc 99m PyrophosphateCardiomyopathiesHumansMaleAgedFemaleCanadaAged, 80 and overRadiopharmaceuticalsRadionuclide Imaging

Stichwörter der Autor:innen

Amyloidosispyrophosphate imagingregistrytransthyretin

Substanzen

Technetium Tc 99m PyrophosphateRadiopharmaceuticals

Autor:innen und Institutionen

  • University of Western Ontario, Medical Imaging, Division of Nuclear Medicine, London, Ontario, Canada.
  • Women's College Hospital, Peter Munk Cardiac Centre, Toronto General Hospital, Toronto, Ontario, Canada.
  • Department of Cardiac Sciences, University of Calgary, Calgary, Alberta, Canada.
  • Department of Nuclear Medicine, Centre Hospitalier de l'Université de Montréal, Montreal, Québec, Canada.
  • Department of Medicine (Cardiology), University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
  • Department of Medical Imaging, Montreal Heart Institute, Montréal, Québec, Canada.

Förderung

  • Pfizer Canada ULC
  • Pfizer

Zitieren

APA

Akincioglu, C., Aleksova, N., Fine, N., Juneau, D., Ruddy, T. D., Small, G., Pelletier-Galarneau, M., Wells, G., & Miller, R. J. H. (2025). Development and Initial Results from the Canadian Cardiac Amyloidosis Pyrophosphate Imaging Registry (CAPER). Canadian Journal of Cardiology. https://doi.org/10.1016/j.cjca.2025.08.357

Vancouver

Akincioglu C, Aleksova N, Fine N, Juneau D, Ruddy TD, Small G, et al. Development and Initial Results from the Canadian Cardiac Amyloidosis Pyrophosphate Imaging Registry (CAPER). Canadian Journal of Cardiology. 2025. doi:10.1016/j.cjca.2025.08.357

BibTeX
@article{Akincioglu2025,
  author = {Akincioglu, Cigdem and Aleksova, Natasha and Fine, Nowell and Juneau, Daniel and Ruddy, Terrence D and Small, Gary and Pelletier-Galarneau, Matthieu and Wells, Glenn and Miller, Robert J H},
  title = {Development and Initial Results from the Canadian Cardiac Amyloidosis Pyrophosphate Imaging Registry (CAPER)},
  journal = {Canadian Journal of Cardiology},
  year = {2025},
  doi = {10.1016/j.cjca.2025.08.357}
}
Kostenlos starten →